RGC
Regencell Bioscience Holdings Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · HK
$6.71
−2.19%Leverage
- Debt / equity
- 0.02x
- Net debt / equity
- -1.04x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.03x
- Net debt / EBITDA
- 1.23x
Liquidity & coverage
- Current ratio
- 10.77x
- Quick ratio
- 10.77x
- Cash ratio
- 10.75x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $12.9M
Cash & dividend
- FCF / debt
- -26.02x
- Cash flow / debt
- -26.02x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- -75.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026